References
- Agostoni A, Cicardi M. Hereditary and acquired Cl-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore). 1993;71:206–15.
- Parish LC. Hereditary angioedema: diagnosis and management—a perspective for the dermatologist. J Am Acad Dermatol. 2011 (Epub).
- Lock RJ, Gompels MM. Cl-inhibitor deficiencies (hereditary angioedema): where are we with therapies? Curr Allergy Asthma Rep. 2007;7:264-9.
- Rottem M, Mader R. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis. J Rheumatol. 2010;37(1):209.
- Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford). 2010;49:1215–28.
- Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, To K, Harashima S, Hatta N, Harada M. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab. Arthritis Rheum. 2008;58(5):1248–57.